MedPath

A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Phase 3
Completed
Conditions
Cystic Fibrosis
Interventions
Drug: IVA
Drug: TEZ/IVA
Registration Number
NCT04058353
Lead Sponsor
Vertex Pharmaceuticals Incorporated
Brief Summary

This study will evaluate the efficacy, safety and pharmacodynamics of elexacaftor (ELX, VX-445) in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic fibrosis (CF) who are heterozygous for F508del and a gating or residual function mutation (F/G and F/RF genotypes).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
271
Inclusion Criteria
  • Subject has a confirmed diagnosis of CF and is heterozygous for F508del and either a gating or residual function mutation (F/G and F/RF genotypes)
  • Forced expiratory volume in 1 second (FEV1) value ≥40% and ≤90% of predicted mean for age, sex, and height

Key

Exclusion Criteria
  • Clinically significant cirrhosis with or without portal hypertension
  • Lung infection with organisms associated with a more rapid decline in pulmonary status
  • Solid organ or hematological transplantation

Other protocol defined Inclusion/Exclusion criteria may apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control: IVA or TEZ/IVAIVAFollowing an IVA or TEZ/IVA run-in period of 4 weeks, participants either received IVA 150 milligrams (mg) every 12 hours (q12h) or TEZ 100 mg once daily (qd)/IVA 150 mg q12h in the treatment period for 8 weeks.
Control: IVA or TEZ/IVATEZ/IVAFollowing an IVA or TEZ/IVA run-in period of 4 weeks, participants either received IVA 150 milligrams (mg) every 12 hours (q12h) or TEZ 100 mg once daily (qd)/IVA 150 mg q12h in the treatment period for 8 weeks.
TC: ELX/TEZ/IVAELX/TEZ/IVAFollowing an IVA or TEZ/IVA run-in period of 4 weeks, participants received ELX 200 mg qd/TEZ 100 mg qd/IVA 150 mg q12h in the treatment period for 8 weeks.
TC: ELX/TEZ/IVAIVAFollowing an IVA or TEZ/IVA run-in period of 4 weeks, participants received ELX 200 mg qd/TEZ 100 mg qd/IVA 150 mg q12h in the treatment period for 8 weeks.
Primary Outcome Measures
NameTimeMethod
Absolute Change in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) for ELX/TEZ/IVA GroupFrom Baseline Through Week 8

FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration.

Secondary Outcome Measures
NameTimeMethod
Absolute Change in ppFEV1 for the ELX/TEZ/IVA Group Compared to the Control GroupFrom Baseline Through Week 8

FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration.

Absolute Change in Sweat Chloride (SwCl) for ELX/TEZ/IVA GroupFrom Baseline Through Week 8

Sweat samples were collected using an approved collection device.

Absolute Change in Cystic Fibrosis Questionnaire-Revised (CFQ-R) Respiratory Domain Score for ELX/TEZ/IVA GroupFrom Baseline Through Week 8

The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for participants with cystic fibrosis. Respiratory domain assessed respiratory symptoms, score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life.

Absolute Change in CFQ-R Respiratory Domain Score for ELX/TEZ/IVA Group Compared to the Control GroupFrom Baseline Through Week 8

The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for participants with cystic fibrosis. Respiratory domain assessed respiratory symptoms, score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life.

Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Day 1 up to Week 12
Absolute Change in SwCl for ELX/TEZ/IVA Group Compared to the Control GroupFrom Baseline Through Week 8

Sweat samples were collected using an approved collection device.

Trial Locations

Locations (93)

Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Children's Hospital of Pittsburgh of UPMC

🇺🇸

Pittsburgh, Pennsylvania, United States

Boston Children's Hospital

🇺🇸

Boston, Massachusetts, United States

Massachusetts General Hospital Cystic Fibrosis Center Clinical Rsearch Center

🇺🇸

Boston, Massachusetts, United States

University of Miami Miller School of Medicine

🇺🇸

Miami, Florida, United States

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Cliniques Universitaires de Bruxelles Hopital Erasme

🇧🇪

Brussels, Belgium

Universitair Ziekenhuis Brussel - Campus Jette

🇧🇪

Brussels, Belgium

HagaZiekenhuis van den Haag

🇳🇱

Den Haag, Netherlands

UMC St. Radboud

🇳🇱

Nijmegen, Netherlands

University of North Carolina Hospitals

🇺🇸

Chapel Hill, North Carolina, United States

University of Utah / Primary Children's Medical Center

🇺🇸

Salt Lake City, Utah, United States

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

University of California San Francisco, Lung Transplant Program

🇺🇸

San Francisco, California, United States

University of Oklahoma Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

Beaumont Hospital

🇮🇪

Dublin, Ireland

Wythenshawe Hospital

🇬🇧

Manchester, United Kingdom

Ospedale Pediatrico Bambino Gesu

🇮🇹

Rome, Italy

Azienda Ospedaliera di Verona-Ospedale Civile Maggiore

🇮🇹

Verona, Italy

Papworth Hospital NHS Foundation Trust, Papworth Everard

🇬🇧

Cambridge, United Kingdom

Centre Hospitalier Lyon Sud

🇫🇷

Benite Cedex, France

Groupe Hospitaler Pellegrin, CHU De Bordeaux

🇫🇷

Bordeaux cedex, France

CHU Marseille - Hopital Nord

🇫🇷

Marseille, France

Mater Adult Hospital

🇦🇺

South Brisbane, Australia

Westmead Hospital

🇦🇺

Westmead, Australia

Universitair Ziekenhuis Gent

🇧🇪

Gent, Belgium

Charite Paediatric Pulmonology Department

🇩🇪

Berlin, Germany

St. Vincent's University Hospital

🇮🇪

Dublin, Ireland

CHRU de Lille - Hopital Albert Calmette

🇫🇷

Lille, France

Clinical Research Facility, Queen Elizabeth University Hospital

🇬🇧

Glasgow, United Kingdom

St. Paul's Hospital

🇨🇦

Vancouver, Canada

Hospital Universitario Virgen del Rocio

🇪🇸

Sevilla, Spain

McGill University Health Center

🇨🇦

Québec, Canada

Queensland Children's Hospital

🇦🇺

South Brisbane, Australia

Hopital Pontchaillou CHU de Rennes

🇫🇷

Rennes Cedex, France

Hopital Cochin

🇫🇷

Paris, France

St. Michael's Hospital

🇨🇦

Toronto, Canada

Ruhrlandklinik Westdeutsches Lungenzentrum am Klinikum Essen

🇩🇪

Essen, Germany

CHU de Montpellier - Hopital Arnaud de Villeneuve

🇫🇷

Montpellier Cedex 5, France

Juliane Marie Center, Rigshospitalet

🇩🇰

Copenhagen, Denmark

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

🇮🇹

Milano, Italy

Hopital Necker, Enfants Malades

🇫🇷

Paris Cedex 15, France

Stollery Children's Hospital

🇨🇦

Edmonton, Canada

Cork University Hospital

🇮🇪

Cork, Ireland

Hospital Universitario y Politecnico La Fe

🇪🇸

Valencia, Spain

Royal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital

🇬🇧

Exeter, United Kingdom

Azienda Ospedaliero Universitaria Ospedale Riuniti

🇮🇹

Ancona, Italy

St. James University Hospital

🇬🇧

Leeds, United Kingdom

Liverpool Heart and Chest Hospital

🇬🇧

Liverpool, United Kingdom

Southampton General Hospital

🇬🇧

Southampton, United Kingdom

University Hospital Wuerzburg

🇩🇪

Würzburg, Germany

Friedrich-Alexander University of Erlangen-Nuremberg, University Children's Hospital

🇩🇪

Erlangen, Germany

Universitätsklinikum Halle (Saale) / Universitätsklinik und Poliklinik für Innere Medizin, Schwerpunkt Pneumologie

🇩🇪

Halle, Germany

Pneumologisches Studienzentrum Muenchen-West

🇩🇪

Muenchen, Germany

Hospital Universitari Vall d´Hebron Servicio de Broncoscopia

🇪🇸

Barcelona, Spain

Hospital Virgen de la Arrixaca

🇪🇸

Murcia, Spain

Banner University of Arizona Medical Center

🇺🇸

Tucson, Arizona, United States

University of California Davis Medical Center

🇺🇸

Sacramento, California, United States

National Jewish Health

🇺🇸

Denver, Colorado, United States

Central Florida Pulmonary Group, PA

🇺🇸

Orlando, Florida, United States

Indiana University

🇺🇸

Indianapolis, Indiana, United States

The University of Iowa Hospitals and Clinics

🇺🇸

Iowa City, Iowa, United States

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

Washington University School of Medicine / St. Louis Children's Hospital

🇺🇸

Saint Louis, Missouri, United States

Northwell Health- Long Island Jewish Medical Center

🇺🇸

New Hyde Park, New York, United States

Dartmouth Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

Mount Sinai Beth Israel

🇺🇸

New York, New York, United States

Columbia University Medical Center

🇺🇸

New York, New York, United States

UC Health Holmes

🇺🇸

Cincinnati, Ohio, United States

Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center

🇺🇸

Cleveland, Ohio, United States

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

ProMedica Toledo Hospital/Toledo Children's Hospital/Pediatric Pulmonary & Cystic Fibrosis Center

🇺🇸

Toledo, Ohio, United States

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

Dell Children's Medical Group

🇺🇸

Austin, Texas, United States

Texas Children's Hospital

🇺🇸

Houston, Texas, United States

University of Washington Medical Center

🇺🇸

Seattle, Washington, United States

University of Wisconsin Hospital and Clinics

🇺🇸

Madison, Wisconsin, United States

Alfred Hospital

🇦🇺

Melbourne, VIC, Australia

The Prince Charles Hospital

🇦🇺

Chermside, Australia

Perth Children's Hospital

🇦🇺

Nedlands, Australia

The Royal Children's Hospital

🇦🇺

Parkville, VIC, Australia

Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

🇧🇪

Leuven, Belgium

Justus-Liebig-Universitaet Gießen Zentrum fur Kinderheilkunde und Jugendmedizin

🇩🇪

Giessen, Germany

University Hospital Limerick (Adults)

🇮🇱

Limerick, Israel

IRCCS Istituto Giannina Gaslini-Ospedale Pediatrico

🇮🇹

Genova, Italy

Malattie Apparato Respiratorio 2 - Fibrosi Cistica

🇮🇹

Orbassano, Italy

University Medical Center, Utrecht, Department of Pulmonology and Tuberculosis

🇳🇱

Heidelberglaan, Netherlands

Royal Brompton & Harefield NHS Foundation Trust, Royal Brompton Hospital

🇬🇧

London, United Kingdom

Michigan Medicine

🇺🇸

Ann Arbor, Michigan, United States

Stanford University

🇺🇸

Palo Alto, California, United States

Miller Children's Hospital / Long Beach Memorial

🇺🇸

Long Beach, California, United States

The University of Texas Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath